Media Library

Leslie Lauersdorf discusses key considerations for nurses and navigators surrounding the use of CAR T-cell therapy in multiple myeloma. View Video ›

Leslie Lauersdorf provides an overview of some of the most exciting clinical developments in multiple myeloma based on data presented at ASH 2019. View Video ›

Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients. View Video ›

Dr Andrey Antov sees much potential for navigators when it comes to applying genetic and genomic testing to cancer care. View Video ›

Dr Andrey Antov expands on how the healthcare team can work together to provide the best possible care for their patient. View Video ›

Dr Andrey Antov recognizes how important the role of the navigator is in dealing with genetic and genomic testing, as the navigator often needs to help the patient gain access to the appropriate therapy, work with different stakeholders, monitor data, and more. View Video ›

Dr Andrey Antov believes it's important for patients to participate in clinical trials for a multitude of reasons, as clinical trials can benefit both the patient and the healthcare system as a whole. View Video ›

Dr Andrey Antov provides an overview of the role of Jackson Laboratory in the field of cancer genetic testing and in the education of nurses and navigators who co-manage patients at high risk or with a diagnosis of cancer. View Video ›

Dr Andrey Antov identifies situations in which people may want to consider genetic testing. View Video ›

Dr Sanjiv Agarwala predicts that the cancer biomarkers of the future may be “mobile biomarkers,” meaning measures of the tumor microenvironment or immune response that change with therapy and may be able to determine treatment efficacy. View Video ›